Cibus (CBUS)
Develops crop traits through gene editing and licenses them to seed companies.
$1.59
After-hours close−0.02 (−1.12%)
At close$1.61(+3.08%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 |
| Cost of revenue | 2 | 0 | 2 | 2 | 0 | 2 | 0 | 0 | 0 | 0 | 1 | 1 |
| Gross profit | −1 | 1 | −1 | −1 | 2 | 0 | 1 | 1 | 1 | 1 | 0 | 0 |
| 25 | 270 | 17 | 21 | 202 | 18 | 43 | 19 | 16 | 15 | 13 | 13 | |
| Research & development | 18 | 14 | 12 | 13 | 13 | 12 | 12 | 12 | 11 | 9 | 9 | 9 |
| Selling, general & administrative | 7 | 7 | 5 | 8 | 8 | 7 | 10 | 7 | 5 | 5 | 5 | 4 |
| Other expenses | 0 | 249 | 0 | 0 | 181 | −2 | 21 | 0 | 0 | 0 | −1 | 0 |
| Operating income | −26 | −269 | −18 | −21 | −200 | −18 | −42 | −18 | −15 | −13 | −12 | −13 |
| −9 | −8 | −9 | −7 | −1 | −8 | −8 | −9 | −9 | −18 | −9 | −9 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 8 | 8 | 8 | 9 | 9 | 8 | 8 | 9 | 9 | 9 | −9 | 9 |
| Other non-operating income | 9 | 0 | 0 | −2 | −8 | 0 | −1 | 0 | 0 | 9 | 0 | 0 |
| Income before tax | −35 | −277 | −27 | −28 | −201 | −26 | −49 | −27 | −24 | −32 | −21 | −22 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | −35 | −277 | −27 | −28 | −201 | −26 | −49 | −27 | −24 | −32 | −21 | −22 |
| Other adjustments | 0 | 70 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
| Net income | −26 | −207 | −23 | −25 | −180 | −23 | −47 | −25 | −24 | −31 | −21 | −22 |
| EPS, basic | −$0.09 | −$12.02 | −$1.12 | −$1.14 | −$7.63 | −$0.83 | −$1.34 | −$0.61 | −$0.44 | −$0.59 | −$0.33 | −$0.29 |
| EPS, diluted | −$0.09 | −$12.02 | −$1.12 | −$1.14 | −$7.63 | −$0.83 | −$1.34 | −$0.61 | −$0.44 | −$0.59 | −$0.33 | −$0.29 |
| Weighted average shares, basic | 391 | 17 | 21 | 22 | 24 | 28 | 35 | 42 | 53 | 53 | 65 | 77 |
| Weighted average shares, diluted | 391 | 17 | 21 | 22 | 24 | 28 | 35 | 42 | 53 | 53 | 65 | 77 |
| EBITDA | −33 | −267 | −17 | −18 | −193 | −16 | −41 | −18 | −15 | −21 | −11 | −12 |
| Depreciation & amortization | 2 | 2 | 2 | 2 | 0 | 2 | 0 | 0 | 0 | 1 | 1 | 1 |
| EBIT | −35 | −269 | −19 | −20 | −193 | −18 | −41 | −18 | −15 | −23 | −12 | −13 |
